Cape Sativa seeks to help mankind realise the promise of cannabis through nanotechnology. Cape Sativa is not a grower of cannabis but has thus invested in the development of scheduled cannabinoid-based products. Cape Sativa has started the development of cannabinoids based pharmaceutical products, some of which are about to enter human trials for the treatment of infectious diseases including COVID and the treatment of Long COVID. Cape Sativa has also advanced the development of treatments for melanoma and non-melanoma skin, cervical and ovarian cancer. Our beverage products are the clearest and clinically formulated in the market, owing to our patented nanotechnology application. Visit us on www.cape-sativa.com